Literature DB >> 23402770

Novel mutations responsible for α-thalassemia in Iranian families.

Nooshin Bayat1, Samaneh Farashi, Nima Hafezi-Nejad, Negin Faramarzi, Mehri Ashki, Shadi Vakili, Hashem Imanian, Mohsen Khosravi, Azita Azar-Keivan, Hossein Najmabadi.   

Abstract

α-Thalassemia (α-thal) is usually caused by deletions on the α-globin gene cluster and the role of point mutations is less well investigated. In the present study, a total of 1048 individuals with hypochromic microcytic anemia, who did not present the most common α-thal deletions, were referred for α-globin gene DNA sequencing. The nucleotide changes were studied and a total of five new mutations was identified, of which three were located on the α2 gene [codon7 (Lys→Stop), codon 34 (Leu→Pro) and codon 83 (Leu→Arg)] and two on the α1 gene [IVS-I-116 (A>G) and codon 44 (+C)]. These novel mutations not only explain new findings by molecular analysis of the α-globin gene but also have clinical importance due to their changes in α-globin production in means of decreased hemoglobin (Hb) related values. Moreover, considerations of its role in combination with other mutations, and the possibility of causing Hb H (β4) are yet to be studied.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23402770     DOI: 10.3109/03630269.2013.763821

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  3 in total

1.  A cytosine-rich splice regulatory determinant enforces functional processing of the human α-globin gene transcript.

Authors:  Xinjun Ji; Jesse Humenik; Stephen A Liebhaber
Journal:  Blood       Date:  2019-03-04       Impact factor: 22.113

2.  First Report of Association Between Rare α-Thalassemia Mutation (HBA1: c.298A>T) and Hb Fontainebleau (HBA2: c.64G>C).

Authors:  Elham Ghadami; Ahmad Tamaddoni; Sadegh Sedaghat; Reza Tabaripour; Hadis Pourreza Baboli; Haleh Akhavan-Niaki
Journal:  Indian J Clin Biochem       Date:  2018-06-18

Review 3.  Hemoglobinopathies in Iran: An Updated Review.

Authors:  Abolfazl Nasiri; Zohreh Rahimi; Asad Vaisi-Raygani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.